Horizon Investments LLC Has $1.12 Million Stock Position in Colgate-Palmolive (NYSE:CL)

Horizon Investments LLC increased its holdings in shares of Colgate-Palmolive (NYSE:CL) by 1.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 12,390 shares of the company’s stock after acquiring an additional 165 shares during the quarter. Horizon Investments LLC’s holdings in Colgate-Palmolive were worth $1,120,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also bought and sold shares of CL. Advisors Asset Management Inc. increased its holdings in Colgate-Palmolive by 22.1% in the 4th quarter. Advisors Asset Management Inc. now owns 78,474 shares of the company’s stock valued at $7,134,000 after buying an additional 14,210 shares during the period. Mystic Asset Management Inc. increased its stake in Colgate-Palmolive by 4.5% in the fourth quarter. Mystic Asset Management Inc. now owns 24,135 shares of the company’s stock valued at $2,194,000 after acquiring an additional 1,038 shares during the last quarter. Axxcess Wealth Management LLC raised its position in Colgate-Palmolive by 0.3% during the fourth quarter. Axxcess Wealth Management LLC now owns 38,786 shares of the company’s stock valued at $3,526,000 after purchasing an additional 117 shares in the last quarter. Flagship Wealth Advisors LLC bought a new stake in Colgate-Palmolive during the fourth quarter worth $100,000. Finally, Cibc World Markets Corp boosted its holdings in shares of Colgate-Palmolive by 20.7% in the 4th quarter. Cibc World Markets Corp now owns 318,671 shares of the company’s stock valued at $28,970,000 after purchasing an additional 54,683 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $90.44 on Thursday. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The company has a 50 day simple moving average of $89.19 and a two-hundred day simple moving average of $94.41. The company has a market capitalization of $73.39 billion, a PE ratio of 25.69, a P/E/G ratio of 4.20 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the previous year, the firm earned $0.87 earnings per share. Research analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on CL. Wells Fargo & Company lowered their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. UBS Group reduced their price target on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research note on Monday, February 3rd. Raymond James reaffirmed an “outperform” rating and set a $105.00 target price (down previously from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. Royal Bank of Canada reiterated a “sector perform” rating and issued a $101.00 price target on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. Finally, TD Cowen reduced their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $101.72.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.